Text and Data Mining valid from 2017-10-01
First Online: 4 October 2017
: J.A.D. is a co-founder of Caribou Biosciences, Editas Medicine and Intellia Therapeutics; a scientific adviser to Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics and Driver; and executive director of the Innovative Genomics Institute at the University of California Berkeley (UC Berkeley) and the University of California San Francisco (UCSF). J.S.C. and J.A.D. are inventors on UC Berkeley and Howard Hughes Medical Institute patents for clustered regularly interspaced short palindromic repeats (CRISPR) technologies.